DNA RNA and Cells

03 Dec 2008 MDRNA Reports UNA-Modified siRNAs Effectively Silence Gene Targets in Animal Models
03 Dec 2008 OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
02 Dec 2008 Targeted Genetics Realigns Product Development Priorities and Implements Cost Reduction Measures
01 Dec 2008 Bioheart Files for Reimbursement Approval in Europe for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure
01 Dec 2008 Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever In Vivo Efficacy Data for a microRNA Therapeutic in a Disease Model
26 Nov 2008 Ceregene Announces Clinical Data from Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
21 Nov 2008 Aastrom Announces Treatment of First Patient in U.S. Phase II IMPACT-DCM Trial
20 Nov 2008 Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program
20 Nov 2008 Aldagen Announces Positive Phase 1/2 Results for Critical Limb Ischemia Stem Cell Therapy ALD-301
19 Nov 2008 Pervasis Therapeutics Announces Promising Efficacy Results from Phase 1 and 2 Clinical Trials of Vascugel(R) in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings
19 Nov 2008 Genvec Announces Intrim Survival Data in Pivotal Trial of TNFERADE(TM) in Locally Advanced Pancreatic Cancer
17 Nov 2008 InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery
13 Nov 2008 ZaBeCor's Investigational New Drug Application Approved by the FDA
11 Nov 2008 Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
10 Nov 2008 Celgene Cellular Therapeutics Receives FDA Clearance for First Placenta-Derived Stem Cell Clinical Study
06 Nov 2008 Pervasis Therapeutics Presents Safety Data from Phase 1 and 2 Clinical Trials of Vascugel(R) at the American Society of Nephrology Annual Meeting
04 Nov 2008 Alnylam and Collaborators Publish Research on a New Class of Chemically Modified RNAi Therapeutics that Target Two Distinct Cellular Mechanisms
04 Nov 2008 Genzyme and Osiris Partner to Develop and Commercialize First-in-Class Adult Stem Cell Products
30 Oct 2008 StemCells, Inc. Announces Preclinical Results Showing its Proprietary Human Neural Stem Cells Can Prevent Vision Loss
29 Oct 2008 Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic
28 Oct 2008 Geron Scientists and Collaborators Demonstrate Activity of Pancreatic Islet-like Cells Derived from Human Embryonic Stem Cells in Diabetes
27 Oct 2008 Ophthotech Enrolls First Patient in a Phase I Complement (Anti-C5) Inhibitor Trial for Macular Degeneration
23 Oct 2008 Novo Nordisk, Cellartis and Lund University enter into a collaboration to develop insulin-producing cells from stem cells for the treatment of diabetes
20 Oct 2008 Archemix Signs Aptamer Therapeutics Agreement with Lilly
20 Oct 2008 Enzon Presents New Data on Its LNA Programs

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top